Point mutations abolish 11 beta-hydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excess.

Source:http://linkedlifedata.com/resource/pubmed/id/8793850

Mol. Cell. Endocrinol. 1996 May 17 119 1 21-4

Download in:

View as

General Info

PMID
8793850